| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.7 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |